10.25384/SAGE.11298278.v1
Francesca Morgante
Francesca
Morgante
Ganesh Bavikatte
Ganesh
Bavikatte
Fahim Anwar
Fahim
Anwar
Biju Mohamed
Biju
Mohamed
APPROVED_Xeomin_Prescribing_information_UKIE_combined_June_2019_v4 – Supplemental material for The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®)
SAGE Journals
2019
sialorrhoea
botulinum toxin
incobotulinumtoxinA
Parkinson’s disease
Motor
neuron disease
2019-11-29 13:06:12
Journal contribution
https://sage.figshare.com/articles/journal_contribution/APPROVED_Xeomin_Prescribing_information_UKIE_combined_June_2019_v4_Supplemental_material_for_The_burden_of_sialorrhoea_in_chronic_neurological_conditions_current_treatment_options_and_the_role_of_incobotulinumtoxinA_Xeomin_/11298278
<p>Supplemental material, APPROVED_Xeomin_Prescribing_information_UKIE_combined_June_2019_v4 for The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®) by Francesca Morgante, Ganesh Bavikatte, Fahim Anwar and Biju Mohamed in Therapeutic Advances in Neurological Disorders</p>